Reflecting on my experience in pharmacy school during the summer of 2016, I remember distinctly the challenging environment of my student internship. Each day commenced at 7:45 a.m. in a buzzing pharmacy, often operating well past 9 p.m. The physical demands of the job were profound; standing for over 13 hours with little to no
Health
Multiple sclerosis (MS) is a chronic and often debilitating autoimmune disease that primarily affects the central nervous system. Emerging research indicates a concerning trend in the treatment of MS, particularly as it relates to gender. Recent findings presented by Dr. Antoine Gavoille at the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) annual
In a significant move aimed at lowering drug costs for consumers, the Federal Trade Commission (FTC) has taken legal action against three major pharmacy benefit managers (PBMs)—Caremark, Express Scripts, and OptumRx. These companies oversee over 80% of prescriptions in the United States, and the FTC’s allegations center around anticompetitive practices that have reportedly contributed to
The intersection of politics and public health has always been fraught with complications, particularly when it comes to the governance of health agencies like the CDC and FDA. The potential influence of Robert F. Kennedy Jr., a prominent vaccine skeptic, in shaping public health policy under a hypothetical second Trump administration raises serious concerns about
The world of public health is a constantly evolving domain, shaped by emerging research, shifting societal norms, and legislative debates. Understanding the intricacies of cardiometabolic health, drug policy, and access to care reveals a tapestry of challenges and opportunities that impact individual lives and communities alike. In this article, we will evaluate several critical issues
Breast cancer remains one of the leading health issues, especially among women. Recent advancements in the treatment landscape have provided new hope to millions of patients worldwide. One such advancement came this week when the U.S. Food and Drug Administration (FDA) approved ribociclib—marketed as Kisqali—alongside endocrine therapy as an adjuvant treatment for early-stage high-risk breast
Muscle-invasive bladder cancer (MIBC) remains a formidable challenge in oncology, often leading to poor outcomes despite aggressive treatment protocols. Traditionally, the standard of care has revolved around radical cystectomy combined with neoadjuvant chemotherapy, particularly for patients eligible for cisplatin-based regimens. However, this approach still leaves a significant proportion of patients—nearly half—with relapsed disease or mortality
The emergence of targeted therapies and immunotherapies has revolutionized the treatment landscape for various malignancies. Among these advancements is retifanlimab (Zynyz), a unique anti-PD-1 monoclonal antibody, which has recently shown significant potential in treating locally advanced or metastatic squamous cell carcinoma of the anal canal (SCAC). The results from a pivotal Phase III trial, presented
Menopause marks a significant transitional phase in a woman’s life, characterized not only by the cessation of menstrual cycles but also by physiological changes that can impact overall health. Among these changes, one of the most pressing is the increased risk of insulin resistance, which can lead to serious metabolic disorders such as diabetes, hyperglycemia,
The debate surrounding reproductive health continues to intensify, particularly with former President Donald Trump’s recent commitment to offer free in vitro fertilization (IVF) treatments. While this initiative targets affordability in reproductive healthcare, it has sparked considerable backlash among various factions within the Republican Party. Critics argue that this policy could shift the party’s stance on